Formulari Ubat KKM (FUKKM)

# Generic Name MDC Category Indications Pres. Restrictions Dosage
301 Chloramphenicol 1% Eye Ointment S01AA01000G5101XX C Treatment of ocular infections involving the conjunctiva and/or cornea caused by chloramphenicol susceptible organisms ADULT and CHILD : Apply to the conjunctiva, a thin strip (approximately 1 cm) of ointment every 3 hours or more frequently
302 Chloramphenicol 250 mg Capsule J01BA01126C1001XX B Treatment of typhoid, paratyphoid fevers, bronchopneumonia and enteric infection ADULT: 500 mg 4 times daily or 50 mg/kg/day in 4 divided doses. Maximum dose: 4 g/day. CHILD: 25 - 100 mg/kg/day in 4 divided doses
303 Chloramphenicol 5% w/v Ear Drops S02AA01000D1001XX C Acute otitis media, otitis externa with perforation Apply 2 - 3 drops into the ear 2 - 3 times daily. Not to be used for long term
304 Chloramphenicol Sodium Succinate 1 g Injection J01BA01520P4001XX B Treatment of typhoid, paratyphoid fevers, bronchopneumonia and enteric infection Adult:50 to 100 mg/kg/day in 4 divided doses. Premature and full-term neonates: 25 mg/kg/day in 4 divided doses. Full-term infants >2 wk: 50 mg/kg/day in 4 divided doses. Children: 50-100 mg/kg/day in 4 divided doses
305 Chlorhexidine 1:200 in Alcohol with Emollient (Hand Disinfectant). D08AC52137L9901XX C+ To be used undiluted for hand and skin disinfections Pre-op surgical hand disinfection: Spread 5ml throughly over both hands and forearms, rubbing vigorously. When dry apply a further 5ml and repeat procedure. Antiseptic hand disinfection on the ward: Spread 3ml throughly over the hands and wrist rubbing vigorously until dry. Disinfection of patient's skin: Prior to surgery, apply to a sterile swab and rub thoroughly over the operation site for a minimum of 2 mins
306 Chlorhexidine Gluconate 0.2 % Mouthwash R02AA05137M2001XX C As a gargle Rinse mouth with 10 ml for about 1 minute twice daily
307 Chlorhexidine gluconate 1% cream D08AC02137G1001XX C+ As a disinfectant cream. It can be used for disinfection or lubricating during gynaecological and obstetric procedures or childbirth. Clean the affected skin area and apply cream as required.
308 Chlorhexidine Gluconate 2% in Alcohol 70% Solution D08AC52137L9902XX C Use as disinfectant in central venous catheter care bundle Skin Preparation: Use Chlorhexidine Gluconate 2% in Isopropyl Alcohol 70% and allow to dry. Catheter access: Apply to catheter ports or hubs prior to accessing the line for administering fluids or injections
309 Chlorhexidine Gluconate 4% Scrub D08AC02137M9901XX C+ Surgical hand scrub/disinfection, pre-op skin preparation Surgical hand disinfection: Apply 5ml to clean hands and forearms for 1 min. Rinse and repeat with another 5ml for a further 2 mins and then rinse and dry. General skin disinfection: Apply appropriate quantity to wet area and scrub for 1 min. Rinse thoroughly & dry
310 Chlorhexidine Gluconate 5% Solution D08AC02137L9901XX C+ i) Preoperative skin disinfection ii) Wounds or burns iii) Emergency disinfection of instruments i) & iii) 1 : 10 in 70 % Alcohol ii) 1 : 100
311 Chlorinated Lime Powder V07AV00000F9901XX C Antiseptic and disinfectants Not applicable
312 Chlorinated Lime Solution & Buffered Acetate Solution D08A000999G9901XX C Wound or ulcer Apply to affected areas undiluted as a cleansing agent
313 Chloroquine Phosphate 250 mg Tablet (150 mg Chloroquine base) P01BA01162T1001XX C Treatment of malaria - acute attack ADULT 600 mg base stat, 300 mg 6 - 8 hours later and a further 300 mg on each of 2 following days. CHILD 3 - 4 years : 150 mg base stat, 75 mg 6 hours later, then 75 mg daily for 2 days. CHILD 5 - 8 years : 300 mg stat, 150 mg 6 hours later, then 150 mg daily for 2 days
314 Chlorpheniramine Maleate 10 mg/ml Injection R06AB04253P3001XX B Allergic conditions 10 - 20 mg IM or SC, repeated if required. Not to exceed 40 mg in 24 hours. 10 - 20 mg over 1 minute by slow IV
315 Chlorpheniramine Maleate 2 mg/5 ml Syrup R06AB04253L9001XX C Symptomatic treatment of allergic conditions responsive to antihistamine CHILD 2 - 5 years : 1 mg every 4 - 6 hours (maximum 6 mg daily) 6 - 12 years : 2 mg every 4 - 6 hours (maximum 12 mg daily)
316 Chlorpheniramine Maleate 4 mg Tablet R06AB04253T1001XX C Symptomatic treatment of allergic conditions responsive to antihistamines ADULT : 4 mg every 4 - 6 hours. Maximum 24 mg daily. CHILD 2 - 5 years : 1 mg every 4 - 6 hours (maximum 6 mg daily) 6 - 12 years : 2 mg every 4 - 6 hours (maximum 12 mg daily)
317 Chlorpromazine HCl 100 mg Tablet N05AA01110T1002XX B Psychosis mania and agitation ADULT : Initial dose - 25 mg 3 times daily according to response up to 1 g daily. PAEDIATRIC: Up to 5 years: 0.5 mg/kg body weight every 4 - 6 hours (Maximum 40 mg daily). CHILD 6 - 12 years: A third to half adult dose (Maximum 75 mg daily)
318 Chlorpromazine HCl 25 mg Tablet N05AA01110T1001XX B Psychosis mania and agitation ADULT : Initial dose - 25 mg 3 times daily according to response up to 1 g daily. PAEDIATRIC: Up to 5 years: 0.5 mg/kg body weight every 4 - 6 hours (Maximum 40 mg daily). CHILD 6 - 12 years: A third to half adult dose (Maximum 75 mg daily)
319 Chlortetracycline 1% Eye Ointment S01AA02000G5101XX B Eye infections requiring a broad spectrum antibiotic Apply thin strip (approximately 1 cm) to the conjuctiva 2 to 4 hourly or more frequently.
320 Chlortetracycline 1-3 % Cream D06AA02000G1001XX B Bacterial skin infections Apply directly to affected area twice daily as required for 1 - 2 weeks
321 Cholera Vaccine J07AE01000P3001XX B Immunisation of cholera Prophylactic ADULT: First dose of 0.5 ml SC/IM followed after 1 - 4 weeks by a second dose of 1 ml. CHILD: 1 - 5 years: 0.1 ml (1st dose), 0.3 ml (2nd dose). CHILD; 5 - 10 years: 0.3 ml (1st dose), 0.5ml (2nd dose). Booster: For optimum long-term protection, a booster dose is recommended for adults after 2 years. Children 2-6 years should receive a booster dose after 6 months.
322 Cholestyramine Resin 4 G C10AC01000M4001XX A i) Hypercholesterolemia ii) Familial hypercholesterolemia - heterozygous iii) Generalized atherosclerosis iv) Diarrhoea due to bile acid malabsorption v) Pruritus of skin associated with partial biliary obstruction Hypercholesterolemia: Adjunct: initial, 4 g orally 1-2 times daily, maintenance, 8 to 16 g in divided doses, max 24 g daily CHILD: 50 - 150 mg/ kg 6 - 8 hourly oral
323 Choline Salicylate 8.7%, Cetylkonium Chloride 0.01% Dental Gel N02BA03900G3001XX B For relief of the pain and discomfort in mouth ulcers and sores, infant teething and denture irritation Apply to area 4 times daily
324 Choriogonadotropin Alfa 250 mcg/0.5 ml Injection in Prefilled Syringe G03GA01000P5001XX A* i)Women undergoing superovulation prior to assisted reproductive techniques such as in-vitro fertilization (IVF) ii)Anovulatory or oligo-ovulatory women 250 mcg 24-48 hour after the last administration of an FSH or hMG preparation, when optimal stimulation of follicular growth is achieved.
325 Chorionic Gonadotrophin Human (HCG) 5000 IU Injection G03GA01000P4001XX A* i)Treatment of infertile women to induce ovulation ii) As a luteal support in controlled ovarian hyperstimulation cycles i) & ii)Induction of ovulation: 5000 - 10,000 units one day following last dose of menotropin. Up to 3 repeat injections of 5000 units each may be given within the following 9 days to prevent insufficiency corpus luteum
326 Ciclesonide 160mcg/dose Inhaler R03BA08000A2101XX A* Prophylactic treatment of asthma in adults, adolescents and children over 6 years. Prescribing restriction: The use of this drug in MOH is restricted to paediatric patient only. For adults and adolescents over 12 years of age with mild to moderate asthma is 160 to 640mcg per day: severe asthma dose may be increased to 1280mcg per day.
327 Ciclosporin 100 mg Capsule L04AD01000C1002XX A* i) Patients in whom donor specific transplantation cannot be carried out and in young children to minimise side-effects of steroids ii) Follow-up cases of bone marrow transplant iii) Patients with severe rheumatoid arthritis not responding to other second line drugs iv) Patients with idiopathic nephrotic syndrome who are steroid toxic or poor response to cyclophosphamide v) Severe aplastic anemia, pure red cell aplasia vi) Cases of recalcitrant psoriasis and atopic eczema vii) Treatment of chronic ocular inflammatory disorders/uveitis i & ii) Initially 12.5 - 15 mg/kg/day, beginning on the day before transplant. Maintenance approx 12.5 mg/kg/day for 3 - 6 months before being tapered off to zero by 1 year of transplantation iii) 3 mg/kg/day in 2 divided doses for first 6 weeks. May increased gradually to maximum 5 mg/kg. Treatment withdrawn if no response after 3 months iv) ADULT: 5 mg/kg/day in 2 divided doses. CHILD: 6 mg/kg/day in 2 divided doses. Patients with permitted levels of kidney failure, the starting dose must not more than 2.5 mg/kg/day v) 12 mg/kg/day vi) 2.5 mg/kg/day in 2 divided doses increasing if there is no improvement after 4 weeks by 0.5 -1 mg/kg/month up to maximum 5 mg/kg/day vii) 5 mg/kg/day in 2 divided doses, may increase to 7 mg/kg/day in resistant cases. Maintenance: Less than 5 mg/kg/day especially during remission
328 Ciclosporin 100 mg/ml Oral Solution L04AD01000L5002XX A* i) Patients in whom donor specific transplantation cannot be carried out and in young children to minimise side-effects of steroids ii) Follow-up cases of bone marrow transplant iii) Patients with severe Rheumatoid arthritis not responding to other second line drugs iv) Patients with idiopathic nephrotic syndrome who are steroid toxic or poor response to cyclophosphamide v) Severe aplastic anaemia, pure red cell aplasia vi) Cases of recalcitrant psoriasis and atopic eczema i & ii) Initially 12.5 - 15 mg/kg/day, beginning on the day before transplant. Maintenance approx 12.5 mg/kg/day for 3 - 6 months before being tapered off to zero by 1 year of transplantation iii) 3 mg/kg/day in 2 divided doses for first 6 weeks. May increased gradually to maximum 5 mg/kg. Treatment withdrawn if no response after 3 months iv) ADULT: 5 mg/kg/day in 2 divided doses. CHILD: 6 mg/kg/day in 2 divided doses. Patients with permitted levels of kidney failure, the starting dose must not more than 2.5 mg/kg/day v) 12 mg/kg/day vi) 2.5 mg/kg/day in 2 divided doses increasing if there is no improvement after 4 weeks by 0.5 -1 mg/kg/month up to maximum 5 mg/kg/day
329 Ciclosporin 25 mg Capsule L04AD01000C1001XX A* i) Patients in whom donor specific transplantation cannot be carried out and in young children to minimise side-effects of steroids ii) Follow-up cases of bone marrow transplant iii) Patients with severe rheumatoid arthritis not responding to other second line drugs iv) Patients with idiopathic nephrotic syndrome who are steroid toxic or poor response to cyclophosphamide v) Severe aplastic anemia, pure red cell aplasia vi) Cases of recalcitrant psoriasis and atopic eczema vii) Treatment of chronic ocular inflammatory disorders/uveitis i & ii) Initially 12.5 - 15 mg/kg/day, beginning on the day before transplant. Maintenance approx 12.5 mg/kg/day for 3 - 6 months before being tapered off to zero by 1 year of transplantation iii) 3 mg/kg/day in 2 divided doses for first 6 weeks. May increased gradually to maximum 5 mg/kg. Treatment withdrawn if no response after 3 months iv) ADULT: 5 mg/kg/day in 2 divided doses. CHILD: 6 mg/kg/day in 2 divided doses. Patients with permitted levels of kidney failure, the starting dose must not more than 2.5 mg/kg/day v) 12 mg/kg/day vi) 2.5 mg/kg/day in 2 divided doses increasing if there is no improvement after 4 weeks by 0.5 -1 mg/kg/month up to maximum 5 mg/kg/day vii) 5 mg/kg/day in 2 divided doses, may increase to 7 mg/kg/day in resistant cases. Maintenance: Less than 5 mg/kg/day especially during remission
330 Ciclosporin 50 mg/ml Injection L04AD01000P3001XX A* i) Post bone marrow transplant ii) Solid organ transplant i) 3 - 5 mg/kg/day until tolerate orally ii) 2 - 3 mg/kg/day for recipients who are unable to take orally

Halaman-halaman